The GoodRx Pharmacist - January 03, 2018
It’s officially 2018, which means it’s time to make those new year’s resolutions.
While it might be easy to stick to the resolutions for a few days, sometimes life can catch up with us. So how do you make those difficult new years resolutions stick? Here are some tips from the pharmacist to help you achieve your goals this year.
Lose those extra pounds
If you’ve decided that 2018 is going to be the year you lose that extra baggage you’ve been carrying—congratulations! Losing weight can help with a number of health problems like diabetes, high cholesterol, and joint problems to name a few. See More
Dr. Sharon Orrange - June 15, 2015
Many Americans struggle with their weight. More than two-thirds of American adults are considered overweight, and one-third are obese. Obesity-related illness is estimated to cost the American economy almost $200 billion a year.
Sadly, there isn’t yet a perfect pill to end obesity. However, there are a variety of prescription options to help you jump-start your weight loss, with a number of new drugs approved in just the past few years. See More
Dr. Sharon Orrange - December 31, 2014
Dr. Sharon Orrange - September 16, 2014
Do we have better meds for weight loss now? September brought news of two new weight loss medications, Contrave and Saxenda. Funny thing is both of them are drugs used for other indications, now approved for weight loss. So these meds have been around, in one form or another. These two will join Belviq, Qsymia, and orlistat (available over the counter as Alli).
Elizabeth Davis - June 11, 2013
Belviq is finally available in pharmacies, nearly a year after its FDA approval in June 2012.
DEA approval was required before the launch because of some of the side effects at higher doses, causing the delay in availability. Belviq is now being released as a Schedule IV drug, the second least restrictive DEA classification. This means it is considered to have a low potential for abuse compared to higher schedules and has an accepted medical use. See More
Dr. Sharon Orrange - September 04, 2012
And away we go! Another weight loss drug, Qsymia, has won FDA approval.
Surprise! The “new” medication for weight loss is a combination of two existing medications. On the heels of Belviq, a weight loss medication approved a month ago, we now have a combination of phentermine and topiramate (Topamax) called Qsymia.
Dr. Sharon Orrange - July 09, 2012
The Food and Drug Administration approved the obesity drug lorcaserin (Belviq) on June 27 despite concerns from physicians and others that it might increase the risk of valve disease.
It may be time to get excited about a new weight loss medication, but let’s get to know it. Previous weight loss medications like Meridia and Fen-phen (fenfluramine + dexfenfluramine) ended up a thing of the past.